Carlson Richard Craig 4
4 · ProUroCare Medical Inc. · Filed Oct 1, 2009
Insider Transaction Report
Form 4
Carlson Richard Craig
DirectorCEO
Transactions
- Award
Stock options
2009-09-29+150,000→ 150,000 totalExercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (150,000 underlying)
Holdings
- 10,000
Stock Options
Exercise: $5.00Exp: 2014-02-01→ Common Stock, $0.00001 par value (10,000 underlying) - 70,000
Stock options
Exercise: $1.00Exp: 2015-07-11→ Common stock, $0.00001 par value (70,000 underlying) - 850
Common Stock, $0.00001 par value
- 100,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (100,000 underlying)
Footnotes (4)
- [F1]The Option shall vest as enumerated: (a) 30,000 shares are vested and currently exercisable; (b) 20,000 shares vest on each of July 1, 2010 and July 1, 2011.
- [F2]Immediately exercisable.
- [F3]90,000 shares immediately exercisable, and 10,000 shares vest on January 2, 2010.
- [F4]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).